Zack Ely
Principal at Longitude Capital
About
Zack Ely is a PhD-trained cancer immunologist and gene-editing specialist who combines active research—co-authoring a 2024 Science paper and maintaining open-source computational biology projects—with board roles in next-generation therapeutics.
Invests in
BiotechHealthtechMedical Devices
Colleagues at Longitude Capital
Advani
Senior Associate at Longitude Capital
Bakker
Managing Director & Founder at Longitude Capital
Bikoff
Managing Director at Longitude Capital
Brian Liu
Managing Director at Longitude Capital
Cabreros
Director of Operations & Facilities at Longitude Capital
Carolyn Helms
Managing Director and CFO at Longitude Capital
Caruso Wilson
Compliance and Legal Manager at Longitude Capital
Chen
Senior Associate at Longitude Capital